In a somewhat surprising but not totally unexpected development, the “VA’s Center for Compassionate Innovation (CCI) will offer Hyperbaric Oxygen Therapy (“HBOT’) to a small number of selected veterans with chronic PTSD in a pilot program to be run through facilities in Oklahoma and Texas.”
SFTT joins Bethesda Hyperbaric Oxygen Therapy (“Bethesda HBOT’) in applauding this initiative by the VA. Bethesda HBOT notes that “worldwide research and years of clinical experience has clearly demonstrated that HBOT is not only extremely safe in treating PTSD and head injury, especially when compared with psychoactive and mood altering drugs, but also has been effective in treating thousands of veterans and active duty service members with underlying brain injury.”
According to a Press Release by the VA’s Office of Public and Intergovernmental Affairs:
“As healthcare leaders interested in innovative approaches to care, the VA Center for Compassionate Innovation (CCI) is facilitating use of HBOT for a subset of Veterans who have noticed no decrease of symptoms after receiving at least two evidenced-based treatments. CCI uses innovative approaches to treat conditions where traditional methods have been unsuccessful. VA will monitor the HBOT clinical demonstration project and the HBOT research study to help inform the potential for HBOT usage to treat a larger number of Veterans with PTSD.”
As SFTT reported earlier, it seems that Secretary David Shulkin agreed to accelerate the use of HBOT for Veterans with PTSD over widespread opposition within the VA.
In fact, the Stars and Stripes article cites some 32 “inconclusive” studies on the effectiveness of HBOT in treating TBI and PTSD. Furthermore, it quotes Col. Scott Miller, the lead study author for a 2015 VA study, arguing that there was a “lack of evidence” HBOT helped and that “he didn’t see any value in moving forward with more studies.” SFTT finds it surprising that Col. Miller was lead on this project when he is reportedly an “infectious disease specialist.”
Several HBOT specialists have suggested that the DoD botched test protocols that let to its “inconclusive” findings.
How does this VA Change in Policy on HBOT Affect Veterans?
It is evident in the Stars and Stripes article that entrenched administrators within the VA are opposed to the use of HBOT in treating Veterans with PTSD and TBI. As SFTT has reported many times, the “High Priests” and Gatekeepers at the VA have mounted a vigorous campaign to discredit the use of HBOT in treating Veterans with brain trauma.
In fact, some 3 years ago, Dr. Xavier Figueroa wrote an article titled “What the <#$*&!> Is Wrong with the DoD/VA HBOT Studies?!!” which clearly articulates the case for HBOT and discredits many of the underlying “evidence-based” positions often cited by the VA and DoD.
Frankly, scientific or clinical evidence is not lacking to support the use of HBOT in treating Veterans with brain trauma. What is lacking is a willingness of the VA to support alternative therapies.
One must hope that the VA will move expeditiously to provide HBOT to “selected Veterans” at CCI facilities in Oklahoma and Texas, but the widespread adoption of HBOT by the VA is still some years away.
Questions for the VA?
- When will initial “testing” begin?
- How many Veterans with “chronic PTSD” be including in the program”
- Who will administer the HBOT test protocols for these Veterans?
- If “legitimate” test results prove encouraging, how will Veterans gain access to HBOT therapy?
- Since HBOT Oxygen Chambers (and qualified personnel) are lacking at VA facilities, will Veterans receive this therapy from the private sector?
- Estimated time frame from evaluating test results to widespread deployment of the HBOT alternative.
While SFTT is delighted that the VA is pressing forward with HBOT, it does seem that it is more of a reaction to public and political pressure rather than any internal VA initiative. Based on years in observing the VA bureaucracy, it is likely that its administrators will do everything possible to discredit this noninvasive and widely accepted therapy to treat PTSD.
Such a shame, but SFTT will be vigilant.